The Sugar Squeeze: Policy Recommendations to Protect Public Health amid Pharma & AYUSH Input Volatility
As the festive season approaches, raw material volatility is a central discussion across India's industrial hubs. For integrated healthcare manufacturers navigating both allopathic and traditional medicines production, the sudden spike in domestic sugar prices presents a unique operational challenge. Rather than reacting to market speculation, it is critical to look at the structural realities behind this trend, as highlighted by The Indian Express and official Press Information Bureau (PIB) data: The Output Reality: Gross domestic sugar production for the current season fell sharply to 306 Lakh Metric Tonnes (LMT), down 11% from initial state estimates of 343 LMT due to climate shocks. Declining Ethanol Diversion: Data confirms the share of sugar diverted to ethanol dropped from 12% in 2022-23 to 9% in 2025-26. Today, nearly three-fourths of India's ethanol is derived from grains like maize, keeping it largely decoupled from sugarcane supply. Global Headwinds: International su...